Direxion Daily S&P Biotech Bull 3X Shares

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LABU and other ETFs, options, and stocks.

About LABU

LABU provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. 

Index-Tracked
S&P 500 TR USD
Index-TrackedS&P 500 TR USD
Category
Trading--Leveraged Equity
CategoryTrading--Leveraged Equity
Number of holdings
168
Number of holdings168
Inception Date
May 28, 2015
Inception DateMay 28, 2015

LABU Key Statistics

AUM
651.09M
AUM651.09M
Price-Earnings ratio
Price-Earnings ratio
30-Day yield
30-Day yield
Average volume
814.32K
Average volume814.32K
High today
$171.50
High today$171.50
Low today
$163.49
Low today$163.49
Open price
$167.94
Open price$167.94
Volume
507.92K
Volume507.92K
52 Week high
$186.25
52 Week high$186.25
52 Week low
$32.55
52 Week low$32.55
Expense ratio
0.93
Expense ratio0.93

Stock Snapshot

With a market cap of 649.7M, Direxion Daily S&P Biotech Bull 3X Shares(LABU) trades at $166.19.

On 2026-01-19, Direxion Daily S&P Biotech Bull 3X Shares(LABU) stock traded between a low of $163.49 and a high of $171.50. Shares are currently priced at $166.19, which is +1.7% above the low and -3.1% below the high.

Direxion Daily S&P Biotech Bull 3X Shares(LABU) shares are trading with a volume of 507.92K, against a daily average of 814.32K.

In the last year, Direxion Daily S&P Biotech Bull 3X Shares(LABU) shares hit a 52-week high of $186.25 and a 52-week low of $32.55.

In the last year, Direxion Daily S&P Biotech Bull 3X Shares(LABU) shares hit a 52-week high of $186.25 and a 52-week low of $32.55.

Average Annual Return

All investments involve risks, including the loss of principal. Performance data represents past performance and is no guarantee of future results. Investment returns and principal value will fluctuate and are subject to market volatility. An investment, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance data quoted. Options are risky and aren’t suitable for all investors. To learn more about risks, read the .